Is Coloplast A/S (CLPBF) a Buy, Sell, or Hold?
OTC : CLPBF
Coloplast A/S — News
$60.06 USD
$0 (0.0%)
- Volume
- 3
- Average Volume
- 1.3K
- Market Capitalization
- $12.45B
- P/E Ratio
- 44.11
- Dividend Yield
- 5.58%
- Price Target
- Year High
- $98.58
- Year Low
- $56.81
- Day High
- —
- Day Low
- —
- Payout Ratio
- $2.46
- Current Ratio
- $1.75
| Source | Headline |
|---|---|
|
Coloplast: Went 'BUY' A Bit Early
Coloplast is rebased to a 20x P/E with a new price target of 490 DKK, reflecting a more realistic valuation post-premiumization. Recent setbacks—the Kerecis acquisition write-down, product recalls, and regulatory shifts—have driven shares down, but core fundamentals and inelastic product demand remain intact. CLPBY now trades at a historically low sub-18x P/E, offering a 5.76% yield and potential 12–13% annualized growth until 2028E, supporting a buy rating. seekingalpha.com - 2026-05-16 10:37:53 |
|
Coloplast A/S (CLPBY) Q2 2026 Earnings Call Transcript
Coloplast A/S (CLPBY) Q2 2026 Earnings Call Transcript seekingalpha.com - 2026-05-12 12:10:51 |
